Aluminium in Alzheimer's disease: Are we still at a crossroad?

Cellular and Molecular Life Sciences

Volumn 62, Issue 2, 2005, Pages 143-158

  Gupta, Veer Bala ^a   Anitha, S ^a   Hegde, M L ^a   Zecca, L ^b   Garruto, R M ^c   Ravid, R ^d   Shankar, S K ^e   Stein, R ^f   Shanmugavelu, P ^g   Jagannatha Rao, K S ^a  

^a CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

^b INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

^c BINGHAMTON UNIVERSITY   (United States)

^d NETHERLANDS BRAIN BANK   (Netherlands)

^e NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^f TEL AVIV UNIVERSITY   (Israel)

^g BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Aluminium; Alzheimer's disease; Amyloid beta; Cell death; Genetics; Neurofibrillary tangles; Oxidative stress

Indexed keywords

ALUMINUM; AMYLOID BETA PROTEIN; CATALASE; COPPER; FREE RADICAL; MONOCARBOXYLATE TRANSPORTER; TAU PROTEIN; TRANSFERRIN; ZINC;

ALUMINUM BLOOD LEVEL; ALUMINUM OVERLOAD; ALZHEIMER DISEASE; APOPTOSIS; BLOOD BRAIN BARRIER; BRAIN FUNCTION; CELL DEATH; ENZYME ACTIVATION; FOOD INTAKE; GENETIC SUSCEPTIBILITY; HOMEOSTASIS; HUMAN; KIDNEY DISEASE; MOLECULAR MECHANICS; NEUROFIBRILLARY TANGLE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; REVIEW;

ALUMINUM; ALZHEIMER DISEASE; ANIMALS; BRAIN; CELL DEATH; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METALS; NEUROFIBRILLARY TANGLES; OXIDATIVE STRESS; RATS;

EID: 19944433257     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4317-3     Document Type: Review

References (163)

1. Alzheimer A. (1906) Über einen eigenartigen schweren Krankheitsprozess der Hirnrinde. Neurologisches Zentralblatt, Leipzig 25: 1134
2. Alzheimer A. (1907) Ueber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und psychisch-gerichtliche Medizin, Berlin 64: 146-148
3. Spafforth J. (1921) Case of aluminium poisoning. Lancet i: 1301
4. McLaughlin A. I. G., Kazantzis G., King E., Teare D., Porter R. J. and Owen R. (1962) Pulmonary fibrosis and encephalopathy associated with the inhalation of aluminum dust. Br. J. Ind. Med. 19: 253-263
5. Dollken V. (1897) Über die Wirkung des Aluminiums mit besonderer Berücksichtigung der durch das Aluminium verursachten Läsionen im Zentralnervensystem. Arch. Exper. Pathol. Pharmacol. 98-120
6. Kerr D. N. S. and Ward M. K. (1988) Metal ions in biological systems. In: Aluminium and Its Role in Biology, vol. 24, pp. 217-258, Sigel H. and Sigel A. (eds). Marcel Dekker, New York
7. Seibert F. B. and Wells H. G. (1929) The effect of aluminum on mammalian blood and tissues. Am. J. Pathol. 8: 230-262
8. Klatzo I., Wisniewski H. M. and Streicher E. (1965) Experimental production of neurofibrillary degeneration. J. Neuropath. Exp. Neurol. 24: 187-199
9. Terry R. D. and Pena C. (1965) Experimental production of neurofibrillary degeneration. J. Neuropath. Exp. Neurol. 24: 200-210
10. Crapper D. R., Krishnan S. S. and Dalton A. J. (1973) Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science 180: 511-513
11. Farnell B. J., De Boni U. and Crapper McLachlan D. R. (1982) Aluminum neurotoxicity in the absence of neurofibrillary degeneration in CAl hippocampal pyramidal neurons in vitro. Exp. Neurol. 78: 241-258
12. Ghetti B. and Gambetti P. (1983) Comparative immuno-cytochemical characterization of neurofibrillary tangles in experimental maytansine and aluminum encephalopathies. Brain Res. 276: 388-393
13. Reusche E. (1997) Argyrophilic inclusions distinct from Alzheimer neurofibrillary changes in one case of dialysis-associated encephalopathy. Acta. Neuropathol. Berl. 94: 612-616
14. Wisniewski H., Terry R. D. and Hirano A. (1970) Neurofibrillary pathology. J. Neuropathol. Exp. Neurol. 29: 163-176
15. Huang Y., Herman M. M., Liu J., Katsetos C. D., Wills M. R. and Savory J. (1997) Neurofibrillary lesions in experimental aluminum-induced encephalopathy and Alzheimer's disease share immunoreactivity for amyloid precursor protein, A beta, alpha 1-antichymotrypsin and ubiquitin-protein conjugates. Brain Res. 771: 213-220
16. Zatta P. (1995) Aluminum binds to the hyperphosphorylated tau in Alzheimer's disease: a hypothesis. Med. Hypotheses. 44: 169-172
17. Savory J., Exley C., Forbes W. F., Huang Y., Joshi J. G., Kruck T. et al. (1996) Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered? J. Toxicol. Environ. Health 30: 615-635
18. Strong M. J., Wolff A. V., Wakayama I. and Garruto R. M. (1991) Aluminium-induced chronic myelopathy in rabbits. Neuro toxicology 12: 9-22
19. Wakayama I., Nerurkar V. R. and Garruto R. M. (1993) Immunocytochemical and ultrastructural evidence of dendritic degeneration in motor neurons of aluminium intoxicated rabbits. Acta Neuropathol. 85: 122-128
20. Wisniewski H. M., Sturman J. A. and Shek J. W. (1980) Aluminum chloride induced neurofibrillary changes in the developing rabbit a chronic animal model. Ann. Neurol. 8: 479-490
21. Munoz-Garcia D., Pendlebury W. W., Kessler J. B. and Perl D. P. (1986) An immunocytochemical comparison of cytoskeletal proteins in aluminium-induced and Alzheimer-type neurofibrillary tangles. Acta Neuropathol. Berl. 70: 243-248
22. Alfrey A. C. (1986) Dialysis encephalopathy. Kidney Int. 29: S53-S57
23. Yokel R. A., Allen D. D. and Ackley D. C. (1999) The distribution of Al into and out of the brain. J. Inorg. Biochem. 76: 127-132
24. Perl D. P. and Good P. F. (1987) Uptake of Al into CNS along nasal-olfactory pathways. Lancet i: 1028
25. Roskams A. J. and Connor J. R. (1990) Aluminium access to the brain: a role for transferrin and its receptor. Proc. Natl. Acad. Sci. USA 87: 9024-9027
26. Gerhart D. Z., Enerson B. E., Zhdankina O. Y., Leino R. L. and Drenes L. R. (1997) Expression of monocarboxylate transporter MCT 1 by brain endothelium and glia in adult and suckling rats. Am. J. Physiol. 273: E207-213
27. 26aluminum in Alzheimer's disease, measured using accelerator mass spectrometry. Dement. Geriatr. Cogn. Disord. 11: 66-69
28. Whitehead M. W., Farrar G., Christie G. L., Blair J. A., Thompson R. P. and Powell J. J. (1997) Mechanisms of aluminum absorption in rats. Am. J. Clin. Nutr. 65: 1446-1452
29. Amstrong R. A., Anderson J., Cowburn J. D., Cox J. and Blair J. A. (1992) Aluminum administered in drinking water but not in the diet influences biopterin metabolism in rodent. Biol. Chem. Hoppe. Seyler 373: 1075-1078
30. Crichton R. R., Florence A. and Ward R. J. (2002) Aluminum and iron in the brain-prospects for chelation. Coord. Chem. Rev. 228: 365-371
31. Morris C. M., Candy J. M., Oakley A. E., Taylor G. A., Mountfort S., Bishop H. et al. (1989) Comparison of the regional distribution of transferrin receptors and aluminum in the forebrain of chronic renal dialysis patient. J. Neurol. Sci. 94: 295-306
32. Banks W. A., Banks A. J. and Zatta P. (1995) The blood-brain barrier in aluminum toxicity and Alzheimer's disease. In: Non-neuronal Cells in Alzheimer's disease, pp. 1-12, Zatta P. and Nicolini M. (eds), World Scientific, Singapore
33. Jagannatha Rao K. S. and Valeswara Rao G. (1995) Aluminum leaching from utensils - a kinetic study. Int. J. Food Sci. Nutr. 46: 31-38
34. Steel M. (1911) On the absorption of aluminium from aluminized food. Am. J. Physiol. 28: 94-102
35. Jagannatha Rao K. S. (1994) Aluminum content in tea leaves and in differently prepared tea infusions. Nahrung 5: 533-537
36. Gies W. J. (1911) Some objections to the use of alum baking powder. J. Am. Med. Assoc. 57: 816-821
37. McLachlan D. R., Bergeron C., Smith J. E., Boomer D. and Rifat S. L. (1996) Risk for neuropathologically confirmed Alzheimer's disease and residual aluminium in municipal drinking water employing weighted residential histories. Neurology 46: 401-405
38. Jacqmin H., Commenges D., Letenneur L., Barberger-Gateau P. and Dartigues J. F. (1994) Components of drinking water and risk of cognitive impairment in the elderly. Am. J. Epidemiol. 139: 48-57
39. Martyn C. N., Barker D. J., Osmand C., Harris E. C., Edwardson J. A. and Lacey R. F. (1989) Geographical relation between Alzheimer's disease and aluminum in drinking water. Lancet 1: 59-62
40. Campbell A., Becaria A., Lahiri D. K., Sharman K. and Bondy S. C. (2004) Chronic exposure to Al in drinking water increases inflammatory parameters selectively in the brain. J. Neurosci. Res. 75: 565-572
41. Rajan M. T., Jagannatha Rao K. S., Mamatha B. M., Rao R. V., Shanmugavelu P., Menon R. B. et al. (1997) Quantification of trace elements in normal human brain by inductively coupled plasma atomic emission spectrometry. J. Neurol. Sci. 146: 153-166
42. Xu N., Majidi Y., Ehmann W. D. and Markesbery W. R. (1992) Determination of aluminum in human brain by electrothermal atomic-absorption spectrometry. Anal. Atom. Spectrom. 7: 749-751
43. Winkelman M. D. and Ricanati E. S. (1986) Dialysis encephalopathy: neuropathologic aspects. Hum. Pathol. 17: 823-833
44. Reusche E., Koch V., Friedrich H. J., Nunninghoff D., Stein P. and Rob P. M. (1996) Correlation of drug-related aluminum intake and dialysis treatment with deposition of argyrophilic aluminum-containing inclusions in CNS and in organ systems of patients with dialysis-associated encephalopathy. Clin. Neuropathol. 15: 342-347
45. McDermott J. R., Smith A. I., Iqbal K. and Wisniewski H. M. (1979) Brain aluminum in aging and Alzheimer's disease. Neurology 29: 809-814
46. Schuurmans Stekhoven J. H., Renkawek K., Otte-Holler I. and Stols A. (1990) Exogenous aluminum accumulates in the lysosomes of cultured rat cortical neurons. Neurosci. Lett. 119: 71-74
47. Lukiw W. J., Krishnan B., Wong L., Kruck T. P. A., Bergeson C. and McLachlan D. R. C. (1991) Nuclear compartmentalization of aluminum in Alzheimer's disease. Neurobiol. Aging 13: 115-121
48. 12 triplet repeats: relevance to neurological disorders. Biochem. Biophys. Acta 1588: 56-64
49. Champion C. S. D., Rajan M. T., Jagannatha Rao K. S. and Viswamitra M. A. (1998) Interaction of Co, Mn, Mg and Al with d(GCCCATGGC) and d(CCGGGCCCGG): a spectroscopic study. Cell. Mol. Life Sci. 54: 488-496
50. Jagannatha Rao K. S. (1992) Effect of aluminum on the brain cells of the rat. Biochem. Int. 28: 51-56
51. Markesbery W. R., Ehmann W. D., Alauddin M. and Hossain T. I. M. (1984) Brain trace element concentrations in aging. Neurobiol. Aging 5: 19-28
52. Ehmann W. D., Markesbery W. R., Alauddin M., Hossain T. I. M. and Brubaker E. H. (1986) Brain trace elements in Alzheimer's disease. Neurotoxicology 7: 195-206
53. Savory J., Jagannatha Rao K. S., Huang Y., Letada P. R. and Herman M. M. (1999) Age-related hippocampal changes in Bcl-2:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: increased susceptibility with aging. Neurotoxicology 20: 805-818
54. Taylor G. A., Ferrier I. N., McLoughlin I. J., Fairbaim A. F., McKeith I. G., Lett D. et al. (1992) Gastrointestinal absorption of aluminum in Alzheimer's disease: response to aluminium citrate. Age Ageing 21: 81-90
55. Roberts N. B., Clough A., Bellia J. P. and Kim J. Y. (1998) Increased absorption of aluminium from a normal dietary intake in dementia. J. Inorg. Biochem. 69: 171-176
56. Banks W. A. and Kastin A. J. (1989) Aluminium-induced neurotoxicity: alterations in membrane function at the blood-brain barrier. Neurosci. Biobehav. Rev. 13: 47-53
57. Shin R. W., Lee V. M. Y. and Trojanowski J. Q. (1994) Aluminium modifies the properties of Alzheimer's disease PHF tau protein in vivo and in vitro. J. Neurosci. 14: 7221-7233
58. Savory J. and Garruto R. M. (1998) Aluminum, tau protein and Alzheimer's disease: an important link? Nutrition 14: 313-314
59. Esclaire E. Lesort M., Blanchard C. and Hugon J. (1997) Glutamate toxicity enhances tau gene expression in neuronal cultures. J. Neurosci. Res. 49: 309-318
60. Good P. F., Perl D. P., Bierer L. M. and Schmeidler J. (1992) Selective accumulation of aluminum and iron in neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 31: 286-292
61. Bugiani O. and Ghetti B. (1982) Progressing encephalomyelopathy with muscular atrophy, induced by Al powder. Neurobiol. Aging 3: 209-222
62. Brun A. and Dictor M. (1981) Senile plaques and tangles in dialysis dementia. Acta Microbiol. Scand. 89: 193-198
63. Molitoris B. A., Alfrey P. S., Miller N. L., Hasbargen J. A., Kaehney W. D., Alfrey A. C. et al. (1987) Efficacy of intramuscular and intraperitoneal desferroxamine for aluminium chelation. Kidney Int. 31: 986-991
64. Seal M. F., Mazurek M. F., Ellison D. W., Kowall N. W., Solomon P. R. and Pendlebury W. W. (1989) Neurochemical characteristics of aluminum-induced neurofibrillary degeneration in rabbits. Neuroscience 29: 339-346
65. Perry E. K. and Perry R. H. (1985) New insights into the nature of senile (Alzheimer type) plaques. Trends Neurosci. 8: 301-303
66. Landsberg I. P., McDonald B. and Watt F. (1992) Absence of aluminium in neuritic plaque cores in Alzheimer's disease. Nature 360: 65-67
67. Perl D. P. and Brody A. R. (1980) Alzheimer's disease: x-ray spectrographic evidence of aluminium accumulation in neurofibrillary tangle-bearing neurons. Science 208: 297-299
68. Lovell M. A., Ehmann W. D. and Marksbery W. R. (1993) Laser microprobe analysis of brain aluminium in Alzheimer's disease. Ann. Neurol. 33: 36-42
69. Wisniewski H. M. and Sofer D. (1979) Neurofibrillary pathology: current status and research perspectives. Mech. Aging Dev. I: 119-142
70. Doll R. (1993) Review: Alzheimer's disease and environmental aluminium. Age and ageing 22: 138-153
71. Barrow C. J., Yasuda A., Kenny P. T. M. and Zagorski M. G. (1992) Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. J. Mol. Biol. 225: 1075-1093
72. Lorenzo A. and Yankner B. A. (1994) β-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. USA 91: 12243-12247
73. Ikezu T., Luo X., Weber G. A., Zhao J., McCabe L. and Buescher J. L. (2003) Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Aβ-mediated neurotoxicity. J. Neurochem. 85: 925-934
74. Tokutake S., Nagase H., Morisaki S. and Oyanagi S. (1995) Al detected in senile plaques and neurofibrillary tangles is contained in lipofuscin granules with silicon, probably as aluminosilicate. Neurosci. Lett. 185: 99-102
75. Evans P. and Harrington C. (1998) Aluminosilicate particulate and beta-amyloid in vitro interactions: a model of Alzheimer plaque formation. Biochem. Soc. Trans. 26: S251
76. Duchen L. W. and Jacobs J. M. (1984) Nutritional deficiencies and metabolic disorders. In: Greenfield's Neuropathology, pp. 595-610, Adams J. H., Corsellis J. A. N. and Duchen L. W. (eds), Wiley, New York
77. Mantyh P. W., Ghilardi J. R., Rogers S., DeMaster E., Allen C. J., Stimson E. R. et al. (1993) Aluminum, iron and zinc ions promote aggregation of physiological concentration of beta-amyloid peptide. J. Neurochem. 61: 1171-1174
78. Kawahara M., Muramoto K., Kobayashi K., Mori H. and Kuroda Y. (1994) Aluminium promotes the aggregation of Alzheimer's amyloid β-protein in vitro. Biochem. Biophys. Res. Commun. 198: 531-535
79. Clauberg M. and Joshi J. G. (1993) Regulation of serine protease activity by Al: Implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 1009-1012
80. Cherny R. A., Atwood C. S., Xilinas M. E., Gray D. N., Jones W. D., McLean C. A. et al. (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30: 665-676
81. Atwood C. S., Obrenovich M. E., Liu T., Chan H., Perry G., Smith M. A. et al. (2003) Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β. Brain Res. Rev. 43: 1-16
82. Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L. and Markesbery W. R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158: 47-52
83. Atwood C. S., Huang X., Moir R. D., Smith M. A., Tanzi R. E., Roher A. E. et al. (2001) Neuroinflammatory responses in the Alzheimer's disease brain promote the oxidative posttranslational modification of amyloid deposits. In: Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics, pp. 341-361, Iqbal K., Sisodia S. S. and Winblad B. (eds), Wiley, New York
84. Curtain C. C., Ali F., Volitakis I., Cherny R. A., Norton R. S., Beyreuther K. et al. (2001) Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J. Biol. Chem. 276: 20466-20473
85. Huang X., Atwood C. S., Hartshorn M. A., Multhaup G., Goldstein L. E., Scarpa R. C. et al. (1999) The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38: 7609-7616
86. Haung X., Cuajugco M. P., Atwood C. S., Hartshorn M. A., Tyadall J., Hanson G. R. et al. (1999) Alzheimer's Aβ interaction with Cu (II) induces neurotoxicity, radicalization, metal reduction and hydrogen peroxide formation. J. Biol. Chem. 274: 37111-37116
87. Yoshiike Y., Tanemura K., Murayama O., Akagi T., Murayama M., Sato S. et al. (2001) New insights on how metals disrupt amyloid β-aggregation and their effects on amyloid-β cytotoxicity. J. Biol. Chem. 276: 32293-32299
88. Jagannatha Rao K. S., Rao R. V., Shanmugavelu P. and Menon R. B. (1999) Trace elements in Alzheimer's disease brain: a new hypothesis. Alz. Rep. 2: 241-246
89. Jagannatha Rao K. S., Shanmugavelu P., Shankar S. K., Rukmini Devi R. P, Rao R. V., Sanjay Pande et al. (1999) Trace elements in the cerebrospinal fluid in Alzheimer's disease. Alz. Rep. 2: 333-338
90. Martin B. R. (1996) Chemistry of aluminium in the central nervous system. In: Mineral and Metal Neurotoxicology, pp. 75-80, Yasui M., Strong M. J., Ota K. and Verity M. A. (eds), CRC Press, New York
91. Strong M. J., Garruto R. M., Joshi J. G., Mundy W. R. and Shafer T. J. (1996) Can the mechanisms of aluminum neurotoxicity be integrated into a unified scheme? J. Toxicol. Environ. Health 48: 599-613
92. Siegel N. and Haung A. (1983) Aluminum interaction with calmodulin. Evidence for altered structure and function from optical and enzymatic studies. Biochem. Biophys. Acta 744: 36-45
93. Bentley D. R. (2000) Decoding the human genome sequence. Hum. Mol. Genet. 9: 2353-2358
94. Trapp G. A. (1980) Studies on aluminium interaction with enzymes and proteins-the inhibition of hexokinase. Neurotoxicology 1: 89-100
95. Zatta P., Lain E. and Cagnolii C. (2000) Effects of aluminium on activity of Kreb's cycle enzymes and glutamate dehydrogenase in rat brain homogenate. Eur. J. Biochem. 267: 3049-3055
96. Zatta P., Bordin C. and Favarato M. (1993) The inhibition of trypsin and chymotrypsin proteolytic activity by aluminium (III). Arch. Biochem. Biophys. 303: 407-411
97. Zatta P., Zambenedetti P. and Milanese M. (1999) Activation of monoamine oxidase type-B by aluminum in rat brain homogenate. Neuroreport 10: 1-4
98. Zatta P., Zambenedetti P., Bruna V. and Filippi B. (1994) Activation of acetylcholinesterase by aluminum (III): the relevance of the metal species. Neuroreport 5: 1777-1780
99. Martin B. R. (1986) The chemistry of Al as related to biology and medicine. Clin. Chem. 32: 1797-1806
100. Yokel R. A. and Golub M. S. (guest eds) (1996) Research issues in aluminium toxicity. J. Toxicol. Environ. Health 48: 527-685
101. Burnet F. M. (1981) A possible role of zinc in the pathology of dementia. Lancet i: 186-188
102. Cuajungco M. P. and Lees G. J. (1997) Zinc and Alzheimer's disease: is there a direct link? Brain Res. 799: 97-107
103. Cuajungco M. P. and Lees G. J. (1997) Zinc metabolism in the brain: relevance to human neurodegenerative disorders. Neurobiol. Dis. 4: 137-169
104. Danscher G., Jensen K. B., Frederickson C. J., Kemp K., Andreasen A., Juhl S. et al. (1997) Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material. J. Neurosci. Methods 76: 53-59
105. Bellia J. P., Newton K., Davenport A., Birchall J. D. and Roberts N. B. (1994) Silicon and aluminum and their interrelationship in serum and urine after renal transplantation. Eur. J. Clin. Invest. 24: 703-710
106. Birchall J. D., Exley C., Chappell J. S. and Phillips M. J. (1989) Acute toxicity of aluminium to fish eliminated in silicon rich acid waters. Nature 338: 146-148
107. Carlisle E. M. and Curran M. J. (1987) Effect of dietary silicon and aluminum on silicon and aluminum levels in rat brain. Alz. Dis. Assoc. Disord. 1: 83-89
108. Fasman G. D. and Moore C. D. (1994) The solubilization of model Alzheimer tangles: reversing the β sheet conformation induced by aluminum with silicates. Proc. Natl. Acad. Sci. USA 9: 11232-11235
109. Smith M. A., Perry G., Richey P. L., Sayre L. M., Anderson V. E., Beal M. F. et al. (1996) Oxidative damage in Alzheimer's. Nature 382: 120-121
110. Smith M. A., Harris P. L., Sayre L. M. and Perry G. (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. USA 94: 9866-9868
111. Christen Y. (2000) Oxidative stress and Alzheimer's disease. Am. J. Clin. Nutr. 71: 621S-629S
112. Smith M. A., Nunomura A., Zhu X., Takeda A. and Perry G. (2000) Metabolic, metallic and mitotic sources of oxidative stress in Alzheimer's disease. Antioxid. Redox Signal. 2: 413-420
113. Gutteridge J. M. C., Quinlan G. J., Clark I. and Halliwell B. (1985) Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts. Biochem. Biophys. Acta 835: 441-447
114. Zatta P., Kiss T., Suwalsky M. and Berthon G. (2002) Aluminum as a promoter of cellular oxidation. Coord. Chem. Rev. 228: 271-284
115. Ellen Y. Y., Guo-Ross S. S. and Bondy S. C. (1999) The stabilization of ferrous iron by a toxic β-amyloid fragment and by an aluminum salt. Brain Res. 839: 221-226
116. Bondy S. C. and Kirstein S. (1996) The promotion of iron-induced generation of ROS in nerve tissue by aluminium. Mol. Chem. Neuropathol. 27: 185-194
117. Ferretti G., Marchionni C., Bacchetti T., Galeazzi T. and Dousset N. (2003) Effect of aluminum on lipid peroxidation of human high density lipoproteins. Free Rad. Res. 37: 515-521
118. Zsiros V., Rojik I., Kovacs T., Csoti T. and Erdelyi L. (1998) Comparative electrophysiological aspects of aluminium actions on central neurons and neuronal synapses of invertebrates and vertebrate animals. Neurotoxicology 19: 553-556
119. Weis C. and Haung A. (1989) Aluminium-altered membrane dynamics in human red blood cell white ghosts. Thrombosis Res. 54: 141-149
120. Fraga C. G., Oteiza P. I., Golub M. S., Gershwin M. E. and Keen C. L. (1990) Effects of aluminium on brain lipid peroxidation. Toxicol. Lett. 51: 213-219
121. Mashiko S., Suzuki N., Koga S., Nakano M., Goto T., Ashino T. et al. (1991) Measurement of rate constants for quenching singlet oxygen with a Cypridina luciferin analog (2-methyl-6-[p-methoxyphenyl]-3,7-dihydroimidazo [1,2-a] pyrazin-3-one) and sodium azide. J. Biolumin. Chemilumin. 6: 69-72
122. Esparza J. L., Gomez M., Romeu M., Mkulero M., Sanchez D. J., Mallol J. et al. (2003) Aluminium-induced pro-oxidant effects in rats: protective role of exogenous melatonin. J. Pineal Res. 35: 32-39
123. Cotman C. W. and Su J. H. (1996) Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol. 6: 493-506
124. Jagannatha Rao K. S., Anitha S. and Latha K. S. (2000) Aluminum-induced neurodegeneration in the hippocampus of aged rabbits mimics Alzheimer's disease. Alz. Rep. 3: 83-88
125. Ghribi O., DeWitt D. A., Forbes M. S., Herman M. M. and Savory J. (2001) Coinvolvement of mitochondria and endoplasmic reticulum in regulation of apoptosis: changes in cytochrome c, Bcl-2 and Bax in the hippocampus of aluminum-treated rabbits. Brain Res. 903: 66-73
126. Savory J., Herman M. M. and Ghribi O. (2003) Intracellular mechanisms underlying aluminium-induced apoptosis in rabbit brain. J. Inorg. Biochem. 97: 151-154
127. Szutowicz A., Bielarczyk H., Kisielevski Y., Jankowska A., Madziar B. and Tomaszewicz M. (1998) Effects of Al and Ca on acetyl CoA metabolism in rat brain mitochondria. J. Neurochem. 71: 2447-2453
128. Suarez-Fernandez M. T. (1999) Aluminum induced degeneration of astrocytes occurs via apoptosis and results in neuronal death. Brain Res. 24: 125-136
129. Su J. H., Deng G. M. and Cotman C. W. (1997) Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain. Brain Res. 774: 193-199
130. Kitamura Y., Shimohama S., Kamoshima W., Ota T., Matsuoka Y., Nomura Y. et al. (1998) Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res. 780: 260-269
131. Anitha S., Shanmugavelu P., Gazula V. R., Shankar S. K., Menon R. B., Rao R. V. et al. (2002) Molecular understanding of aluminum bioinorganic chemistry in relevance to the pathology of Alzheimer's disease. In: Group 13 Chemistry: From Fundamentals to Applications (ACS Symposium Series), vol. 822, pp. 228-245, American Chemical Society, Washington, DC
132. Dayde S., Brumas W., Champmartin D., Rubini P. and Berthon G. (2003) Aluminum speciation studies in biological fluids. Part 9. A quantitative investigation of aluminum (III)-flutamate complex equilibria and their potential implications for aluminum metabolism and toxicity. J. Inorg. Biochem. 97: 104-117
133. Flaten T. P. and Garruto R. M. (1992) Polynuclear ions in aluminum toxicity. J. Theor. Bio. 156: 129-132
134. Crapper D. R. and Tomko G. J. (1975) Neuronal correlates of an encephalopathy associated with Al neurofibrillary degeneration. Brain Res. 97: 253-264
135. Bjertness E., Candy J. M., Torvik A., Ince P., McArthur F., Taylor G. A. et al. (1996) Content of brain aluminum is not elevated in Alzheimer's disease. Alz. Dis. Assoc. Disord. 10: 171-174
136. McDermott J. R., Smith A. I., Iqbal K. and Wisniewski H. M. (1977) Aluminum and Alzheimer's disease. Lancet 2: 710-711
137. Scholtz C. L., Swash M., Gray A., Kogeorgos J. and Marsh F. (1987) Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminium toxicity. Clin. Neuropathol. 6: 93-97
138. Hirayama A., Horikoshi Y., Maeda M., Ito M. and Takashima S. (2003) Characteristic development expression of amyloid beta 40, 42 and 43 in patients with Down's syndrome. Brain Dev. 25: 180-185
139. Savory J., Ghribi O. and Herman M. M. (2002) Is amyloid beta peptide neurotoxic or neuroprotective and what is its role in binding of metal ions? Neurobiol. Aging 23: 1089-1092
140. Savory J., Huang Y., Wills M. R. and Herman M. M. (1998) Reversal by desferrioxamine of tau protein aggregates following 2 days of treatment in aluminum-induced neurofibrillary-degeneration in rabbit: implications for clinical trials in Alzheimer's disease. Neurotoxicology 19: 209-214
141. Ward R. J., Zhang Y. and Crichton R. R. (2001) Aluminum toxicity and iron homeostasis. J. Inorg. Biochem. 87: 9-14
142. Heininger K. (2000) A unifying hypothesis of Alzheimer's disease. III. Risk factors. Hum. Psychopharmacol. 15: 1-70
143. Grant W. B., Campbell A., Itzhaki R. F. and Savory J. (2002) The significance of environmental factors in the etiology of Alzheimer's disease. J. Alzheimers Dis. 4: 179-189
144. Zatta P., Lucchini R., Rensburg S. J. and Taylor A. (2003) The role of metals in neurodegenerative processes: aluminum, manganese and zinc. Brain Res. Bull. 62: 15-28
145. Golub M. S. and Domingo J. L. (1997) What we know and what we need to know about developmental aluminum toxicity. In: Research Issues in Aluminum Toxicity, pp. 585-597, Yokel R. A. and Golub M. S. (eds), Taylor and Francis, Washington, DC
146. Mullan M., Houlden H. and Windelspecht M. (1992) A locus for familial early onset Alzheimer's disease on the long arm of chromosome 14 proximal to the alphal antichymotrypsin gene. Nat. Genet. 2: 340
147. Hyslop P. H. (1987) The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 238: 664-666
148. Sherrington R., Rogaev E. I. and Liang Y. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760
149. Schellenberg G. D., Bird T. D. and Wijsman E. M. (1992) Genetic linkage evidence for a familial Alzheimer's disease locus chromosome 14. Science 258: 668-671
150. Rogaev E. I., Sherrington R., Rogaev E. A., Levesque G., Ikeda M., Liang Y. et al. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376: 775-778
151. Levy-Lahad E., Wissman E. M., Nemens E., Anderson L., Goddard K. A., Weber J. L. et al. (1995) A familial Alzheimer's disease locus on chromosome 1. Science 269: 970-973
152. Betard C., Robitaille Y., Gee M., Tiberghien L. D., Roy P., Mortimer J. A. et al. (1994) ApoE allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuroreport 5: 1893-1896
153. Strittmater W. J., Saunders A. M., Schmechel D., Pericakvnce M., Enghild J., Salvesen G. S. et al. (1993) Apoplipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90: 1977-1981
154. Perez-Tur J., Campion D., Martinez M., Brice A., Tardieur S., Hannequin D. et al. (1995) Evidence for ApoE ε4 association in early-onset Alzheimer's disease patients with late onset relatives. Am. J. Med. Genet. 60: 550-553
155. Van Broeckhoven C. (1995) Molecular genetics of Alzheimer disease: Identification of genes and gene mutations. Eur. Neurol. 35: 8-19
156. Gauthier E., Fortier I., Courchesne F., Pepin P., Mortimer J. and Gauvreau D. (2000) Aluminum forms in drinking water and risk of Alzheimer's disease. Environ. Res. 84: 234-246
157. Van Rensburg S. J., Carstens M. E., Potocnik F. C. V., Aucamp A. K. and Taljaard J. J. F. (1993) Increased frequency of the transferrin C2 subtype in Alzheimer's disease. Neuroreport 4: 1269-1271
158. Namekata K., Imagawa M., Terashi A., Ohta S., Oyama F. and Ihara Y. (1997) Association of transferrin C2 allele with late onset Alzheimer's disease. Hum. Genet. 101: 126-129
159. Van Landeghem G. F., Sikstrom C., Beckman L. E., Adolfsson R. and Beckman L. (1998) Transferrin C2, metal binding in Alzheimer's disease. Neuroreport 9: 177-179
160. Meco G., Bonifati V., Vanacore N. and Fabrizio E. (1994) Parkinsonism after chronic exposure to the fungicide maneb. Scand. J. Work Environ. Health 20: 301-305
161. Van Rensburg S. J., Potocnik F. C. V., De Villers J. N. P., Kotze M. J. and Taljaard J. J. F. (2000) Earlier age of onset of Alzheimer's disease in patients with both the transferrin C2 and apolipoprotein Epsilon 4 alleles. Ann. N. Y. Acad. Sci. 903: 200-203
162. Fosmire G. J., Focht S. J. and McClearn G. E. (1993) Genetic influences on tissue deposition of aluminum in mice. Biol. Trace Elem. Res. 37: 115-121
163. Matsuzaki S., Manabe T., Katayama T., Nishikawa A., Yanagita T., Okuda H. et al. (2004) Metals accelerate production of the aberrant splicing isoform of the presenilin-2. J. Neurochem. 88: 1345-1351